Rocket


News + Filings
Transactions


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Rottinghaus Scott T. Create: Alert

All | News | Filings
Date FiledTypeDescription
11/28/2022 4 Rottinghaus Scott T. (Chief Medical Officer) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns: Granted 7,000 shares @ $0
Granted 15,000 options to buy @ $45, valued at $675k
08/11/2022 4 Rottinghaus Scott T. (Chief Medical Officer) has filed a Form 4 on ENANTA PHARMACEUTICALS INC
Txns: Granted 20,000 shares @ $0
Granted 75,000 options to buy @ $71.27, valued at $5.3M
08/11/2022 3 Rottinghaus Scott T. (Chief Medical Officer) has filed a Form 3 on ENANTA PHARMACEUTICALS INC

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy